Osteo Drug Stops Bone Loss From Breast Cancer Chemo (HealthDay)

On August 21, 2008 in Weight Loss

HealthDay - THURSDAY, Aug. 21 (HealthDay News) — The osteoporosis drug Zometa (zoledronic acid) prevented bone loss at 12 months in premenopausal women undergoing chemotherapy after they had surgery for early stage breast cancer, a new study found.

Original post by Herbal-Review.com

Comments (0)